148 related articles for article (PubMed ID: 34077091)
1. Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study.
Ohazurike E; Olamijulo JA; Ibisomi L; Olorunfemi G; Oluwole AA
Afr J Reprod Health; 2020 Jun; 24(2):48-63. PubMed ID: 34077091
[TBL] [Abstract][Full Text] [Related]
2. Jadelle subdermal implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria.
Enyindah CE; Kasso T
Niger J Med; 2011; 20(2):270-4. PubMed ID: 21970242
[TBL] [Abstract][Full Text] [Related]
3. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
4. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Power J; French R; Cowan F
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
6. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
Coukell AJ; Balfour JA
Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
[TBL] [Abstract][Full Text] [Related]
8. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
10. The acceptance rate of intrauterine contraceptive device (IUCD) amongst family planning clinic users in Lagos University Teaching Hospital (LUTH).
Adegbola O; Ogedengbe OK
Nig Q J Hosp Med; 2008; 18(4):175-80. PubMed ID: 19391314
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.
Moutchia-Suh J; Mouemba DM; Ngwasiri CA
J Med Case Rep; 2018 Apr; 12(1):111. PubMed ID: 29704897
[TBL] [Abstract][Full Text] [Related]
12. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
13. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
14. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
Roke C; Roberts H; Whitehead A
J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Norplant implants among Thai women in Bangkok.
Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
[TBL] [Abstract][Full Text] [Related]
16. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
17. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria.
Pam VC; Mutihir JT; Nyango DD; Shambe I; Egbodo CO; Karshima JA
Niger Med J; 2016; 57(6):314-319. PubMed ID: 27942097
[TBL] [Abstract][Full Text] [Related]
19. Contraception with levonorgestrel subdermal implants (Norplant) in Benin-City, Nigeria: a 12-year review.
Aisien AO
Afr J Reprod Health; 2007 Apr; 11(1):90-7. PubMed ID: 17982951
[TBL] [Abstract][Full Text] [Related]
20. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital.
Laphikanont W; Taneepanichskul S
J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
